These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10942954)

  • 21. How can we improve our use of oral anticoagulants?
    Alpert JS
    Am J Med; 2006 Feb; 119(2):101-2. PubMed ID: 16443407
    [No Abstract]   [Full Text] [Related]  

  • 22. PIVKA-II is a candidate marker for monitoring the effects of the oral anticoagulant warfarin.
    Lee W; Chung HJ; Kim S; Jang S; Park CJ; Chi HS; Chun S; Min WK
    Clin Biochem; 2010 Sep; 43(13-14):1177-9. PubMed ID: 20621074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of rosuvastatin on warfarin pharmacodynamics and pharmacokinetics.
    Simonson SG; Martin PD; Mitchell PD; Lasseter K; Gibson G; Schneck DW
    J Clin Pharmacol; 2005 Aug; 45(8):927-34. PubMed ID: 16027403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. International Normalized Ratio fluctuation with warfarin-fluorouracil therapy.
    Carabino J; Wang F
    Am J Health Syst Pharm; 2002 May; 59(9):875. PubMed ID: 12004471
    [No Abstract]   [Full Text] [Related]  

  • 25. Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms.
    Crowther MA
    Semin Vasc Med; 2003 Aug; 3(3):255-60. PubMed ID: 15199458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and pharmacodynamics of warfarin when coadministered with pentosan polysulfate sodium.
    Modi NB; Kell S; Simon M; Vargas R
    J Clin Pharmacol; 2005 Aug; 45(8):919-26. PubMed ID: 16027402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple doses of sitagliptin, a selective DPP-4 inhibitor, do not meaningfully alter pharmacokinetics and pharmacodynamics of warfarin.
    Wright DH; Herman GA; Maes A; Liu Q; Johnson-Levonas AO; Wagner JA
    J Clin Pharmacol; 2009 Oct; 49(10):1157-67. PubMed ID: 19783710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Warfarin and extractions.
    Brown AE
    Br Dent J; 2002 Dec; 193(12):668. PubMed ID: 12536981
    [No Abstract]   [Full Text] [Related]  

  • 29. CYP2C9 and oral anticoagulation therapy with acenocoumarol and warfarin: similarities yet differences.
    Takahashi H; Wilkinson GR; Padrini R; Echizen H
    Clin Pharmacol Ther; 2004 May; 75(5):376-80. PubMed ID: 15116049
    [No Abstract]   [Full Text] [Related]  

  • 30. Response to warfarin and other oral anticoagulants: effects of disease states.
    Demirkan K; Stephens MA; Newman KP; Self TH
    South Med J; 2000 May; 93(5):448-54; quiz 455. PubMed ID: 10832939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gender differences in pharmacokinetics of oral warfarin in rats.
    Zhu X; Shin WG
    Biopharm Drug Dispos; 2005 May; 26(4):147-50. PubMed ID: 15776499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suspected suppression of the INR by thiazolidinediones: interaction between warfarin and TZDs.
    Hoffmann TK; Parker DL; Buch HA; Balusu P
    Ann Pharmacother; 2006 May; 40(5):994-6. PubMed ID: 16670367
    [No Abstract]   [Full Text] [Related]  

  • 33. Why warfarin and heparin need to overlap when treating acute venous thromboembolism.
    Wittkowsky AK
    Dis Mon; 2005; 51(2-3):112-5. PubMed ID: 15900262
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of oral versus intravenous phytonadione in patients with excessive anticoagulation.
    Key N
    Curr Hematol Rep; 2004 Sep; 3(5):315-6. PubMed ID: 15341696
    [No Abstract]   [Full Text] [Related]  

  • 35. The perioperative management of warfarin therapy.
    Ansell JE
    Arch Intern Med; 2003 Apr; 163(8):881-3. PubMed ID: 12719195
    [No Abstract]   [Full Text] [Related]  

  • 36. Absence of a pharmacokinetic interaction between etanercept and warfarin.
    Zhou H; Patat A; Parks V; Buckwalter M; Metzger D; Korth-Bradley J
    J Clin Pharmacol; 2004 May; 44(5):543-50. PubMed ID: 15102876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral vitamin K produces a normal INR within 24 hours of its administration in most patients discontinuing warfarin.
    Crowther MA; Ageno W; Schnurr T; Manfredi E; Kinnon K; Garcia D; Douketis JD
    Haematologica; 2005 Jan; 90(1):137-9. PubMed ID: 15642685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence-based initiation of warfarin (Coumadin).
    Ebell MH
    Am Fam Physician; 2005 Feb; 71(4):763-5. PubMed ID: 15742915
    [No Abstract]   [Full Text] [Related]  

  • 39. Perioperative management of patients receiving oral anticoagulants.
    Kearon C; Hirsh J
    Arch Intern Med; 2003 Nov; 163(20):2532-3; author reply 2533. PubMed ID: 14609792
    [No Abstract]   [Full Text] [Related]  

  • 40. Evidence-based adjustment of warfarin (Coumadin) doses.
    Ebell MH
    Am Fam Physician; 2005 May; 71(10):1979-82. PubMed ID: 15926414
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.